Daxor Corporation (DXR)
NASDAQ: DXR · Real-Time Price · USD
13.63
-0.07 (-0.51%)
Jan 16, 2026, 4:00 PM EST - Market closed
Daxor Market Cap
Daxor has a market cap or net worth of $67.94 million as of January 16, 2026. Its market cap has increased by 72.02% in one year.
Market Cap
67.94M
Enterprise Value
68.20M
1-Year Change
72.02%
Ranking
Category
Stock Price
$13.63
Market Cap Chart
Since September 3, 1985, Daxor's market cap has increased from $30.27M to $67.94M, an increase of 124.46%. That is a compound annual growth rate of 2.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 68.29M | -7.12% |
| Dec 31, 2025 | 73.52M | 97.53% |
| Dec 31, 2024 | 37.22M | -19.10% |
| Dec 29, 2023 | 46.01M | 17.82% |
| Dec 30, 2022 | 39.05M | -14.22% |
| Dec 31, 2021 | 45.52M | -6.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |